Data-driven care for patients with neurodegenerative disorders

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Standard

Data-driven care for patients with neurodegenerative disorders. / Waldemar, Gunhild.

I: Nature Reviews Neurology, Bind 19, Nr. 8, 2023, s. 447-448.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Harvard

Waldemar, G 2023, 'Data-driven care for patients with neurodegenerative disorders', Nature Reviews Neurology, bind 19, nr. 8, s. 447-448. https://doi.org/10.1038/s41582-023-00828-9

APA

Waldemar, G. (2023). Data-driven care for patients with neurodegenerative disorders. Nature Reviews Neurology, 19(8), 447-448. https://doi.org/10.1038/s41582-023-00828-9

Vancouver

Waldemar G. Data-driven care for patients with neurodegenerative disorders. Nature Reviews Neurology. 2023;19(8):447-448. https://doi.org/10.1038/s41582-023-00828-9

Author

Waldemar, Gunhild. / Data-driven care for patients with neurodegenerative disorders. I: Nature Reviews Neurology. 2023 ; Bind 19, Nr. 8. s. 447-448.

Bibtex

@article{ad8cafbffb544f0fae0d8ab32f5e1ade,
title = "Data-driven care for patients with neurodegenerative disorders",
abstract = "Data-driven approaches hold considerable promise for medical breakthroughs in the precision and cost-effectiveness of the prevention, diagnosis and treatment of neurodegenerative diseases. The scientists and health care professionals who will be responsible for providing the evidence to support these approaches must also consider the ethical challenges involved in the care of people with intellectual impairments.",
author = "Gunhild Waldemar",
year = "2023",
doi = "10.1038/s41582-023-00828-9",
language = "English",
volume = "19",
pages = "447--448",
journal = "Nature Reviews. Neurology",
issn = "1759-4758",
publisher = "nature publishing group",
number = "8",

}

RIS

TY - JOUR

T1 - Data-driven care for patients with neurodegenerative disorders

AU - Waldemar, Gunhild

PY - 2023

Y1 - 2023

N2 - Data-driven approaches hold considerable promise for medical breakthroughs in the precision and cost-effectiveness of the prevention, diagnosis and treatment of neurodegenerative diseases. The scientists and health care professionals who will be responsible for providing the evidence to support these approaches must also consider the ethical challenges involved in the care of people with intellectual impairments.

AB - Data-driven approaches hold considerable promise for medical breakthroughs in the precision and cost-effectiveness of the prevention, diagnosis and treatment of neurodegenerative diseases. The scientists and health care professionals who will be responsible for providing the evidence to support these approaches must also consider the ethical challenges involved in the care of people with intellectual impairments.

U2 - 10.1038/s41582-023-00828-9

DO - 10.1038/s41582-023-00828-9

M3 - Comment/debate

C2 - 37400548

AN - SCOPUS:85163746826

VL - 19

SP - 447

EP - 448

JO - Nature Reviews. Neurology

JF - Nature Reviews. Neurology

SN - 1759-4758

IS - 8

ER -

ID: 366981460